Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Biochim Biophys Acta Gen Subj. 2018 Oct 17;1863(1):232–240. doi: 10.1016/j.bbagen.2018.10.006

Figure 3.

Figure 3.

Analysis of specificity of dimeric R1.2 constructs against mIgM negative SKLY16 knockout cells. Evaluation of negative mIgM in CRISPR/CAS9 SKLY-16 knockout cells against SKLY16 wild type and analysis of binding of dimeric aptamer constructs to SKLY-16 knockout and wild-type (A). Overall conclusion from three independent binding studies against knockout SKLY-16 cells (B).